Hagen Kennecke, Section chief and Chief Health Officer of the OHSU Knight-Legacy Health Cancer Collaborative, shared on X:
“Possible breakthrough in cancer cachexia with Ponsegromab, anti-GDF 15. Significant weight gain, especially in patients with colorectal cancer.”
Ponsegromab for the Treatment of Cancer Cachexia | NEJM
Authors: John D. Groarke, Jeffrey Crawford, Susie M. Collins, Shannon Lubaczewski, Eric J. Roeland, Tateaki Naito, Andrew E. Hendifar, Marie Fallon, Koichi Takayama, Timothy Asmis, Richard F. Dunne, M.D., Isik Karahanoglu, Carrie A. Northcott, Magdalena A. Harrington, Michelle Rossulek, Ruolun Qiu, Aditi R. Saxena
Source: Hagen Kennecke/X